QDx Granted FDA Emergency Use Authorization
September 28, 2022
QDx Pathology is pleased to announce FDA emergency use authorization for testing of at-home, self-collected SARS-CoV-2 samples when ordered by a provider. (FDA-EUA20366).
QDx Pathology is pleased to announce FDA emergency use authorization for testing of at-home, self-collected SARS-CoV-2 samples when ordered by a provider. (FDA-EUA20366).